Dr. Krasna provides a thoughtful review of thoracoscopy as an emerging technique for the staging
of patients with lung and esophageal cancers. In lung cancer, thoracoscopy can be used as a
complement to cervical mediastinoscopy in the evaluation of mediastinal and hilar lymph nodes. This
is especially true in patients who have left-sided neoplasms with enlarged lymph nodes in the
aortico-pulmonary window--a region typically inaccessible to cervical mediastinoscopy.
Perhaps the most useful application of thoracoscopy is in the preoperative assessment of patients
with pulmonary lesions abutting the mediastinum. Of nine patients with lung cancer in Dr. Krasna's
review who underwent thoracoscopic staging, three were found to have mediastinal invasion and
thus avoided an unnecessary thoracotomy. Similarly, thoracoscopy enables evaluation of the pleural
space, such that the presence of pleural implants or invasion can be assessed preoperatively. As Dr.
Krasna points out, however, routine thoracoscopic evaluation of the pleural cavity prior to all
thoracotomies for lung cancer is not indicated currently, and this technique should be limited to a
study setting at this time.
Potential Benefits in Staging of Esophageal Cancer
The potential benefits of thoracoscopy in patients with esophageal cancer include improved staging
so that an adequate determination of prognosis with present therapies can be made, as well as
selection of the appropriate treatment modality for each disease stage. Lymph node involvement
occurs in the majority of patients with esophageal cancer, including, in most studies, those
undergoing curative surgical resection. Although the accuracy of endoscopic ultrasound for
T-staging is 85%, its accuracy for lymph node involvement is only 75%. By contrast, the results
reported by Krasna suggest that 93% accuracy for lymph node involvement may be possible with
Information about lymph node status is essential, as the number of lymph nodes involved is
predictive of prognosis in patients managed with esophagectomy. Abe et al  found no survivors if
two or more nodes were involved.
Skinner et al  and Sieward  observed no survivors if five or more nodes were involved,
whereas Ellis et al  found that patients with one to four positive nodes had a survival intermediate
to that of patients with no involved nodes or more than four positive nodes.
Information regarding the extent of the esophageal tumor at thoracoscopy may also be important for
patients initially managed with a nonsurgical approach, such as chemoradiation alone,
chemoradiation followed by surgical resection, or chemotherapy followed by surgical resection. At
present, patients initially managed with a nonsurgical approach must be staged using the 1983
American Joint Committee on Cancer (AJCC) clinical staging system, or one must rely on the
accuracy of ultrasound to appropriately stage patients with the 1988 AJCC criteria. As the volume
of tissue irradiated correlates with morbidity, accurate information regarding lymph node
involvement provided by video-assisted thoracoscopy may permit the use of tailored radiation fields
that conform more closely to the actual regions of involvement, potentially resulting in a reduction in
morbidity. Nearly two-thirds of the patients treated with chemoradiation in the landmark study by
Herscovic et al  developed grade 3 or 4 acute toxicity, including esophagitis and hematologic
toxicity, which could be attributed, at least in part, to the use of relatively generous radiation fields,
typically encompassing the nodes from the supraclavicular area to the gastroesophageal junction.
1. Abe S, Tachibana M, Shiraishi M, et al: Lymph node metastasis in resectable esophageal cancer.
J Thorac Cardiovasc Surg 100:287-291, 1990.
2. Skinner DB, Dowlatshahi KD, DeMeester TR: Potentially curable cancer of the esophagus.
Cancer 50:2571-2575, 1982.
3. Sieward JR: Esophageal cancer from the German point of view. Jpn J Surg 19:11-20, 1989.
4. Ellis FH Jr, Watkins E, Krasna MJ, et al: Staging of carcinoma of the esophagus and cardia: A
comparison of different staging criteria. J Surg Oncol 55:231-235, 1993.
5. Herskovic A, Marta K, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy
compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med
6. Yim AP, Ho JK: Video-assisted thoracoscopic lobectomy: A word of caution. Aust NZ J Surg
7. Kirby TJ, Mack MJ, Landreneau RJ, et al: Lobectomy--video-assisted thoracic surgery versus
muscle-sparing thoracotomy: A randomized trial. J Thorac Cardiovasc Surg 109(5):997-1002,
8. Walsh GL, Nesbitt JC: Tumor implants after thoracoscopic resection of a metastatic sarcoma.
Ann Thorac Surg 59(1):215-216, 1995.
9. McCormack PM, Ginsberg KB, Bains MS, et al: Accuracy of lung imaging in metastases with
implications for the role of thoracoscopy. Ann Thorac Surg 56(4):863-866, 1993.
10. Santambrogio L, Nosotti M, Bellaviti N, et al: Videothoracoscopy versus thoracotomy for the
diagnosis of the indeterminate solitary pulmonary nodule. Ann Thorac Surg 59(4):868-871, 1995.
11. Shennib HA, Landreneau R, Mulder DS, et al: Video-assisted thoracoscopic wedge resection
of T1 lung cancer in high-risk patients. Ann Surg 218(4):555-560, 1993.